|
|
|
EDITOR’S TAKE: THE HIDDEN DATA GAPS IN DECENTRALIZED TRIALS
|
|
|
|
|
|
By John Oncea, chief editor, Clinical Tech Leader
|
Wearables and decentralized technology were meant to reduce patient burden. Learn why outcomes depend on thoughtful study design, not technology alone.
|
|
|
|
|
|
Why Wearable Timestamp Drift Can Undermine Trial Data
|
|
By John Oncea, chief editor, Clinical Tech Leader
|
Timestamp drift between wearable sensors can quietly compromise decentralized trial data. Learn why synchronization must be designed and monitored from the start.
|
|
|
|
AI, DATA, AND TRIAL DECISIONS UNDER PRESSURE
|
|
|
|
|
|
|
|
|
|
How Drug Price Controls Could Reshape Clinical Innovation
|
|
By ISPOR—The Professional Society for Health Economics and Outcomes Research
|
Explore how U.S. drug-pricing policies, including the IRA and international reference pricing, could affect investment, access, and future innovation.
|
|
|
|
|
|
|
|
TOOLS FOR SIMPLER PATIENT AND TRIAL EXPERIENCES
|
|
|
|
|